Global X HealthTech ETF (NASDAQ:HEAL) Sees Large Growth in Short Interest

Global X HealthTech ETF (NASDAQ:HEAL) was the target of a significant growth in short interest in August. As of August 14th, there was short interest totaling 15,534 shares, a growth of 103.9% from the July 30th total of 7,620 shares. Currently, 1.5% of the shares of the stock are sold short. Based on an average daily volume of 6,569 shares, the days-to-cover ratio is currently 2.4 days.

Institutional Investors Weigh In On Global X HealthTech ETF

A number of hedge funds have recently made changes to their positions in HEAL. Flow Traders U.S. LLC bought a new stake in Global X HealthTech ETF in the third quarter worth $368,000. Citadel Advisors LLC purchased a new position in shares of Global X HealthTech ETF in the third quarter worth about $216,000. Raymond James Financial Inc. purchased a new position in shares of Global X HealthTech ETF in the third quarter worth about $274,000. Daiwa Securities Group Inc. bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter valued at about $11,239,000. Finally, Banque Cantonale Vaudoise bought a new stake in shares of Global X HealthTech ETF in the 3rd quarter valued at about $37,000.

Global X HealthTech ETF Price Performance

Shares of NASDAQ:HEAL opened at $29.72 on Friday. Global X HealthTech ETF has a one year low of $23.00 and a one year high of $33.59. The company’s fifty day moving average price is $28.22 and its 200-day moving average price is $26.30. The firm has a market capitalization of $31.50 million, a price-to-earnings ratio of 42.80 and a beta of 1.10.

Global X HealthTech ETF Company Profile

An ETF that invests in companies at the intersection of healthcare and technology, targeting innovations in drug discovery, medical devices, consumer healthcare, and analytics.